|
September 2011 |
An overview on AREDS, AREDS2 and observational studies supporting new approaches to nutritional therapy
A leading specialist explains why it can make sense to recommend the AREDS2 formulation now
The leader of the AREDS2 research group analyzes data, recommendations and current practices from her perspective at the National Eye Institute
Evidence-based recommendations provide the basis of an effective approach
The dean of AMD risk prevention research reflects on 25 years of progress and adds a unique perspective on current thinking